For prenatal specimens only: If amniotic fluid (nonconfluent cultured cells) is received, amniotic fluid culture/genetic test will be added and charged separately. If chorionic villus specimen (nonconfluent cultured cells) is received, fibroblast culture for genetic test will be added and charged separately.
If this test is ordered in conjunction with CMAP / Chromosomal Microarray, Prenatal, Amniotic Fluid/Chorionic Villus Sampling or CMAPC / Chromosomal Microarray, Autopsy, Products of Conception, or Stillbirth, and no other molecular testing is ordered, test will be changed to PPAP / Parental Sample Prep for Prenatal Microarray Testing, Blood.
FLT3; NPM1; CEPBA; IDH1; IDH2; KRAS; NRAS; TP53; Next generation sequencing of leukemia; Next Gen Sequencing Test; NGS for acute myeloid leukemia evaluation; NGS hematologic malignancies; Somatic mutation detection by next generation sequencing (NGS), hematologic; DNMT3A; KIT; RUNX1; NGAML; Enasidenib therapy; Gilteritinib therapy; Ivosidenib therapy; Next-Gen Sequencing, Acute Myeloid Leukemia (NGAML)
NGS Acute Myeloid Leukemia, Therapeutic Gene Mutation Pnl (FLT3, IDH1, IDH2, TP53), Varies (NGAMT); FLT3; IDH1; IDH2; Next gen sequencing of leukemia (AML); Next Gen Sequencing Test; NGS cancer panel, hematologic; NGS hematologic malignancies; Somatic mutation detection by next generation sequencing (NGS), hematologic; TP53; Enasidenib therapy; Midostaurin therapy; Gilteritinib therapy; Ivosidenib therapy; NGS for Acute Myeloid Leukemia evaluation
This test includes next-generation sequencing to evaluate for the following 4 genes: FLT3, IDH1, IDH2, and TP53.
NGS hematologic malignancies, NGS cancer panel, hematologic, Somatic mutation detection by next generation sequencing (NGS), hematologic, Next gen sequencing of leukemia (AML) and myelodysplasia (MDS), NGS for myeloid neoplasm evaluation (MPN), Next Gen Sequencing Test, ASXL1, BCOR, CALR, CBL, CEBPA, CSF3R, DNMT3A, ETV6, EZH2, FLT3, GATA1, GATA2, IDH1, IDH2, JAK2, KIT, KRAS, MPL, NPM1, NRAS, PHF6, PTPN11, RUNX1, SETBP1, SF3B1, SRSF2, TERT, TET2, TP53, U2AF1, WT1, ZRSR2, ANKRD26, DDX41, ELANE, ETNK1, KDM6A, RAD21, SH2B3, SMC3, STAG2, BCORL1, BRAF, Enasidenib therapy, Gilteritinib therapy, Ivosidenib therapy, Midostaurin therapy, NF1, PPM1D, STAT3, UBA1, Mayo Complete
Carboxypeptidase M (CPM)
Rubeola (Measles) Ab, IgG, IgM, S
Rubeola Antibodies, IgG and IgM (Separate Determinations), Serum
Measles (Rubeola) Ab, IgM
Measles (Rubeola) Ab, IgG
Measles IgG Antibody Index
Hg (Mercury), Mercury (Hg)
Mercury, Urine 24 Hour (HGU)
Bicarbonate, Urea Nitrogen, Total Calcium, Chloride, Creatinine, Glucose, Potassium, Sodium, Anion Gap, and Estimated glomerular filtration rate
*i-Stat MPB includes all of the above tests EXCEPT has an Ionized Calcium, NOT a Total Calcium.
Mycoplasma hominis PCR, Mycoplasma hominis, Metamycoplasma hominis
MGMT Promoter Methyl, T (MGMT)
Cross reactive with peppermint and spearmint, Mentha Piperita, Mint (Mentha Piperita) IgE (FMINT)
mtDNA, MELAS, Myoclonic Epilepsy with Ragged Red Fibers, MERRF, Neurogenic Muscle Weakness, Ataxia, and Retinitis Pigmentosa, NARP, Leigh syndrome, LHON, Chronic progressive external ophthalmoplegia, CPEO, Pearson syndrome, Next Gen Sequencing Test, Leber's hereditary optic neuropathy, Kearns-Sayre syndrome
For skin biopsy or cultured fibroblast specimens, fibroblast culture testing will be performed at an additional charge. If viable cells are not obtained, the client will be notified.
Slide review; MLH1 Hypermethylation Analysis
BRAF Mutation, BRAF V600E, Hypermethylation, MLH1 Hypermethylation, Promoter Hypermethylation, MLBRF, Lynch syndrome
MOG-IgG; MOG; Optic Neuritis Antibody; Transverse Myelitis Antibody; Vision Loss Antibody; ADEM antibody; NMO antibody
When the results of this assay require further evaluation, the reflex titer test (MOGTS) will be performed at an additional charge.
Mouse Urine Protein, IgE, Serum, Common House Mouse Urine Protein, House Mouse Urine Protein, Mouse Urine Protein, Muss pp. Mouse
M-Protein Isotype, Serum (MALD), Immunofixation, Immunosubtraction, Isotyping, Mass-Fix, miRAMM, Multiple Myeloma, MassFix
Bromelain, CCD, Glycans
Acetylcholine Receptor (Muscle AChR) Antibodies, Ach Receptor Ab, AChR (Acetylcholine Receptor), AChR Receptor Blocking Ab, Anti-Skeletal Muscle Antibodies, Binding, Blocking, and Modulating Abs, Blocking Ab, Muscle End-Plate Antibodies, MUSK, MuSK myasthenia, Myasthenia Gravis Antibodies, Myasthenia Gravis, Myoid Antibody, Thymoma
ACh Receptor (Muscle) Binding Ab
Acetylcholine Receptor (Muscle AChR) Antibodies, Ach Receptor Ab, AChR (Acetylcholine Receptor), AChR Receptor Blocking Ab, Anti-Skeletal Muscle Antibodies, Binding, Blocking, and Modulating Abs, Blocking Ab, Muscle End-Plate Antibodies, MUSK, MuSK myasthenia, Myasthenia Gravis Antibodies, Myasthenia Gravis, Myoid Antibody, Thymoma, LEMS, LES, Lambert-Eaton Myasthenic syndrome, Lambert Eaton, Lambert-Eaton syndrome, P/Q, Calcium channel antibody
P/Q-Type Calcium Channel Ab
Acid-Fast Bacilli (AFB)
AFB (Acid-Fast Bacilli)
Culture, TB (Tuberculosis)
MTB (Mycobacterium tuberculosis)
Mycobacterium tuberculosis (MTB)
TB (Tuberculosis) Culture
Tubercle Bacilli: Mycobacterium tuberculosis
Mycoplasma pneumoniae, Mycoplasmoides pneumoniae
Mycoplasma pneumoniae, Mycoplasmoides pneumoniae
MYD88, L265, Somatic Gene Mutation, DNA Allele-Specific PCR, Varies (MYD88), MYD88, L265P, B-cell lymphoma, LPL/WM, Lymphoplasmacytic lymphoma, Waldenstrom's macroglobulinemia
Myoglobin, Random, U (MYGLU)
FMMPP Myositis Panel 3 Plus Myomarker 3 plus Myo Marker 3 Plus Myo 3 Plus Myositis
MyoMarker3 Plus Prof(FMMPP)
FMYO3 Myositis Panel 3 Myomarker 3 Myositis